 |
40K PEGylated recombinant factor IX |
|---|---|
| Trade Name | |
| Orphan Indication | Routine prophylactic administration for prevention of bleeding in patients with hemophilia B (Christmas disease) |
| USA Market Approval | USA |
| USA Designation Date | 2013-03-18 00:00:00 |
| Sponsor | Novo Nordisk, Inc.;100 College Road West;Princeton, 08540 |
